Fig. 2From: Anticancer traits of chimeric antigen receptors (CARs)-Natural Killer (NK) cells as novel approaches for melanoma treatmentVarious therapeutic approaches to enhance the anticancer effects of NK cells; allogenic NK cells are developed for infusions, and genetically modified NK cells which include those for homing (CXCR4, CCR7), for activation (NKG2D-DAP10, scFV and endoplasmic NKG2A), for proliferation (mbIL-15) and for tumor retargeting (CAR-NK cells)Back to article page